Inhaled pirfenidone solution (AP01) for IPF: A randomised, open-label, dose-response trial

- West, Alex, Chaudhuri, Nazia, Wijsenbeek, Marlies S., Grainge, Christopher, Piotrowski, Wojciech, Raghu, Ganesh, Shaffer, Michele L., Nair, Deepthi, Freeman, Lisa, Otto, Kelly, Montgomery, A. Bruce, Barczyk, Adam, Wilsher, Margaret L., Hopkins, Peter, Glaspole, Ian, Corte, Tamera Jo, Šterclová, Martina, Veale, Antony, Jassem, Ewa

Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing

- Burgess, Andrew, Goon, Ken, Brannan, John D., Attia, John, Palazzi, Kerrin, Oldmeadow, Christopher, Corte, Tamera J., Glaspole, Ian, Goh, Nicole, Keir, Gregory, Allan, Heather, Chapman, Sally, Cooper, Wendy, Ellis, Samantha, Hopkins, Peter, Moodley, Yuben, Reynolds, Paul, Zappala, Chris, Macansh, Sacha, Grainge, Cristopher

Thoracic ultrasound recognition of competence: a position paper of the Thoracic Society of Australia and New Zealand

- Williamson, Jonathan P., Twaddell, Scott H., Grainge, Christopher, Lee, Y. C. Gary, Salamonsen, Matthew, Hew, Mark, Fielding, David, Nguyen, Phan, Steinfort, Daniel, Hopkins, Peter, Smith, Nicola

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

- Jo, Helen E., Troy, Lauren K., Whitford, Helen, Chapman, Sally, Reynolds, Paul N., Glaspole, Ian, Beatson, David, Jones, Leonie, Hopkins, Peter, Corte, Tamera J., Keir, Gregory, Chambers, Daniel C., Holland, Anne, Goh, Nicole, Wilsher, Margaret, de Boer, Sally, Moodley, Yuben, Grainge, Christopher